[Serum levels of IAP, CEA and CA19-9 in patients with urological malignancies]

Autor:	H Muramatsu, H Amemiya, Atsushi Toyoshima, Tatsuo Iizumi, Masayoshi Waku, Takeo Kariba, Shoji Kaneko, Tsunetada Yazaki, R. Hata
Rok vydání:	1988
Předmět:	Male medicine.medical_specialty Urologic Neoplasms business.industry Urology Prognosis Gastroenterology Carcinoembryonic Antigen Neoplasm Proteins Internal medicine medicine Biomarkers Tumor Humans CA19-9 In patient Antigens Tumor-Associated Carbohydrate business Aged Neoplasm Staging
Zdroj:	Nihon Hinyokika Gakkai zasshi. The japanese journal of urology. 79(8)
ISSN:	0021-5287
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384df68e7752706df3a62c6a7dc52a49 https://pubmed.ncbi.nlm.nih.gov/3246830 Zobrazit plný text záznamu